header
Hill-Rom Selects NanoHorizons to Provide Antimicrobial Protection for Hill-Rom Products Using NanoTechnology

New relationship between NanoHorizons and Hill-Rom delivers patient support systems enhanced with revolutionary antimicrobial technology
 
ABOUT NANOHORIZONS, INC.

NanoHorizons, Inc., (www.nanohorizons.com) with its solid foundation in applied chemistry and engineering, is a leader in the emerging field of practical nanotechnology. NanoHorizon¿s SmartSilverTM antimicrobial offers permanent bacterial control for textiles, medical devices and industrial materials. NanoHorizons is privately held and headquartered in State College, PA. The company works closely with customers from its R&D laboratory, manufacturing facility, and technical support office adjacent to The Penn State University.

ABOUT HILL-ROM.

Hill-Rom, an operating company of Hillenbrand Industries, Inc., is a leading worldwide manufacturer and provider of medical technologies and related services for the health care industry, including patient support systems, non-invasive therapeutic products for a variety of acute and chronic medical conditions, medical equipment rentals, and workflow information technology solutions. Hill-Rom¿s comprehensive product and service offerings are used by health care providers across the health care continuum in hospitals, extended care facilities and home care settings to enhance the safety and quality of patient care.Hill-Rom¿enhancing outcomes for patients and their caregivers.

 
Hillenbrand Disclosure Regarding Forward-Looking StatementsCertain statements in this press release contain forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, regarding the Company's future plans, objectives, beliefs, expectations, representations and projections. The Company has tried, wherever possible, to identify these forward-looking statements using words such as "intend," "anticipate," "believe," "plan," "encourage," "expect," "may," "goal," "become," "pursue," "estimate," "strategy," "will," "projection," "forecast," "continue," "accelerate," "promise," "increase," ¿higher,¿ ¿lower,¿ ¿reduce,¿ ¿improve,¿ ¿expand,¿ ¿progress,¿ ¿potential¿ or the negative of those terms or other variations of them or by comparable terminology. The absence of such terms, however, does not mean that the statement is not forward-looking. It is important to note that forward-looking statements are not guarantees of future performance, and the Company's actual results could differ materially from those set forth in any forward-looking statements. Factors that could cause actual results to differ from forward-looking statements include but are not limited to: the Company's dependence on its relationships with several large national providers and group purchasing organizations, changes in death rates, whether the Company's new products are successful in the marketplace, changes in customers' Medicare reimbursements, collections of accounts receivable, compliance with FDA regulations, antitrust litigation, potential exposure to product liability or other claims, failure of the Company's announced strategic initiatives and restructuring and realignment activities to achieve expected growth, efficiencies or cost reductions, disruptions in the Company's business or other adverse consequences resulting from the planned separation of the Company's two operating companies, failure of the Company to execute its acquisition and business alliance strategy through the consummation and successful integration of acquisitions or entry into joint ventures or other business alliances, competition from nontraditional sources in the funeral services business, volatility of the Company's investment portfolio, increased costs or unavailability of raw materials, labor disruptions, the ability to retain executive officers and other key personnel, and certain tax-related matters. For a more in depth discussion of these and other factors that could cause actual results to differ from those contained in forward-looking statements, see the discussions under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the period ended September 30, 2007 and in Amendment 1 to the Batesville Holdings, Inc., Form 10. The Company assumes no obligation to update or revise any forward-looking statements.


Media Contact
Lauren Green-Caldwell
Director Corporate Communications & Public Relations
(812)934-8692
Lauren.Green-Caldwell@hillenbrand.com


Investor Relations
Blair A. (Andy) Rieth
Vice President Investor Relations & Global Brand Development
(812)931-2199
Andy.Rieth@Hillenbrand.com